Skip to Main Content

A former Sun Pharmaceuticals sales rep has filed a lawsuit claiming he was fired for balking at alleged off-label marketing practices, the latest in a growing number of incidents concerning business practices at one of the world’s largest generic drug makers.

In his lawsuit, Damian Frantz contended that company policy prohibiting illegal marketing was ignored and, instead, that a supervisor “expressly directed” him to “do whatever is needed to get” a clinical team to “talk off label” to physicians and health plans, among others. In general, the company sought to “aggressively solicit opportunities to present off-label information to decision-makers about its drugs.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.